New Thresholds for AFP and Des-γ-Carboxy Prothrombin in Chronic Liver Disease Depending on the Use of Nucleoside Analogs and an Integrated Nomogram
Ting Sun,1 Ruicen Li,2 Yiwen Qiu,1 Shu Shen,1 Wentao Wang1 1Department of Liver Surgery & Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, People’s Republic of China; 2Health Management Center, West China Hospital of Sichuan University, Chengdu, People’s Republic...
Main Authors: | Sun T, Li R, Qiu Y, Shen S, Wang W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-09-01
|
Series: | International Journal of General Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/new-thresholds-for-afp-and-des--carboxy-prothrombin-in-chronic-liver-d-peer-reviewed-fulltext-article-IJGM |
Similar Items
-
Next-generation des-r-carboxy prothrombin for immunohistochemical assessment of vascular invasion by hepatocellular carcinoma
by: Shintaro Yamazaki, et al.
Published: (2020-09-01) -
Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients
by: Pan YX, et al.
Published: (2021-06-01) -
Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
by: Lee Yong Kang, et al.
Published: (2013-01-01) -
Diagnostic value of combined detection of abnormal prothrombin and other two indicators in AFP-negative primary liver cancer patients
by: XU Hanfeng, et al.
Published: (2023-09-01) -
Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma
by: Kelley G. Núñez, et al.
Published: (2021-09-01)